Trials / Completed
CompletedNCT00293696
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
A Randomised Pilot Study to Evaluate the Effect(s) of Casodex 150 mg and Zoladex 3.6 mg on Pathological and Genomic Tumour Markers in Subjects Undergoing Radical Prostatectomy for Localised Prostate Carcinoma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Tampere University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate anti-androgen (bicalutamide) induced biological and molecular changes in prostate comparison to chemical castration induced (goserelin) ones
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bicalutamide (Casodex), goserelin (Zoladex) |
Timeline
- Start date
- 2004-10-01
- Completion
- 2006-11-01
- First posted
- 2006-02-17
- Last updated
- 2007-05-08
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT00293696. Inclusion in this directory is not an endorsement.